BP
MLSS icon

Ballentine Partners’s Milestone Scientific MLSS Stock Holding History

Ballentine Partners’s Portfolio MLSS Stock Details MLSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-37,500
Closed -$47K – 404
2017
Q3 		$47K Hold
37,500
– – ﹤0.01% 413
2017
Q2 		$47K Buy
+37,500
New +$52.4K ﹤0.01% 403

Other funds holding MLSS

GCM
Goldman Capital Management New York $103M AUM 21.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GHAM
Gilman Hill Asset Management New Canaan, Connecticut $731M AUM 19.41% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ballentine Partners's MLSS Position: Q4 2017 in Review

Ballentine Partners sold out of Milestone Scientific (MLSS) in Q4 2017, closing a stake of 37,500 shares — an estimated $47K sold.

Ballentine Partners first reported a position in MLSS in Q2 2017 and held it in 2 quarters. The position peaked at $47K in Q3 2017. 12 funds tracked by Wall St. Rank hold MLSS as of Q4 2017.

  • Ballentine Partners reported no remaining Milestone Scientific position as of Q4 2017 after selling out during the quarter.
  • Ballentine Partners sold 37,500 Milestone Scientific shares in Q4 2017, an estimated $47K.
  • Ballentine Partners first reported a position in Milestone Scientific in Q2 2017 and held it in 2 quarters.
  • Ballentine Partners's Milestone Scientific position peaked at $47K in Q3 2017.
  • 12 funds tracked by Wall St. Rank held Milestone Scientific as of Q4 2017.

Based on Ballentine Partners's 13F filing for Q4 2017, filed 2 Feb 2018.